Polymorphism of CYP2C19 and gastric emptying in patients with proton pump inhibitor-resistant gastric ulcers

Journal of International Medical Research

Volumn 30, Issue 4, 2002, Pages 413-421

  Wada, F ^a   Murase, K ^a   Isomoto, H ^a   Soda, H ^a   Takeshima, F ^a   Omagari, K ^a   Mizuta, Y ^a   Tsukamoto, K ^a   Murata, I ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

13C acetate breath test; Gastric emptying; Polymorphism of CYP2C19; Proton pump inhibitor resistant gastric ulcer

Indexed keywords

ACETIC ACID; CARBON 13; CYTOCHROME P450 2C19; LANSOPRAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME POLYMORPHISM; EXCRETION; EXON; FEMALE; GENE MUTATION; HUMAN; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH EMPTYING; STOMACH ULCER; ULCER HEALING; VOLUNTEER;

EID: 0036630514     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000203000408     Document Type: Article

References (37)

1. Randomized double-blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer
2. Effect of omeprazole and cimetidine on duodenal ulcer. A double-blind comparative trial
3. Prospective multicentre study of risk factor associated with delayed healing of recurrent duodenal ulcer (RUDER)
4. Risk factors associated with refractory peptic-ulcers
5. Clinicopathological study of background gastric mucosa during long-term conservative maintenance therapy for intractable peptic ulcer
6. Is there any acid peptic disease that is refractory to proton pump inhibitors?
7. Overuse of proton pump inhibirors
8. Efficacy of famotidine for omerprazole-refractory gastric ulcer
9. Clinical study on the pathophysiology and treatment of PPI-resistant ulcers
10. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking
11. Study of outcome after targeted intervention for peptic ulcer resistant to acid suppression therapy
12. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole
13. Metabolic interactions of the proton-punp inhibitors lansoprazole, omeprazole and pantoprazole with other drugs
14. Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism
15. Effect of gastric pH on absorption of new anti-ulcer drug (lansoprazole) in the beagle dog
16. Phase I study of lansoprazole (AG-1749). Anti-ulcer tablet form
17. Gastric emptying measurement in man
18. 13C-acetate breath test for the noninvasive assessement of the gastric emptying of a liquid/solid test meal in diabetics
19. Genotyping of N-acetylation polymorphism and correlation with procainamide metabolism
20. Identification of a new genetic defect responsible for the polymorphism of (S)- mephenytoin metabolism in Japanese
21. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test
22. 13C-acetate breath test for the measurement of a gastric emptying rates
23. Biochemistry and molecular biology of the human CYP2C19 subfamily
24. Interphenotype differences in disposition and effect on gastrin levels of omeprazole: Suitability of omeprazole as a probe for CYP2C19
25. Cure of refractory duodenal ulcer and infection caused by Helicobacter pylori by high doses of omeprazole and amoxicillin in a homozygous CYP2C19 extensive metabolizer patient
26. Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations
27. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and interphenotypic differences in diazepam pharmacokinetics
28. Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, CYP2C19m1 in exon 5 and CYP2C19m2 in exon 4, in Japanese subjects
29. Measurement of gastric emptying rates by radioactive isotope scanning and epigastric impedance
30. Inter- and intrasubject variability of solid and liquid gastric emptying parameters. A scintigraphic study in healthy subjects and diabetic patients
31. Disturbed gastric motor activity in patients with human immunodeficiency virus infection
32. Noninvasive (13)C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis
33. Gastric emtying in normal subjects and patients with peptic ulcer. A study using the acetaminophen method
34. Biochemical toxicology of acetaminophen
35. Gastric emptying in patients with gastric and duodenal ulcer
36. Gastric acid secretion and gastric emptying liquids in 99 male duodenal ulcers patients
37. Effects of trimebutine maleate on gastric motility in patients with gastric ulcer